Global Human Microbiome Market Size, Share, and COVID-19 Impact Analysis, By Product (Drugs, Probiotics, Prebiotics, and Synbiotics), By Disease (Infectious, Gastrointestinal, and Endocrine & Metabolic), By Type (BCT/FMT and Live Biotherapeutics), By End User (Hospitals & Clinics and Long-term Care), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE May 2025
REPORT ID SI10327
PAGES 250
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Product
      2. Market Attractiveness Analysis By Disease
      3. Market Attractiveness Analysis By Type
      4. Market Attractiveness Analysis By End User
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Significance of the microbiome’s role in health and disease
      2. Surging trend of personalized medicine
    3. Restraints
      1.  Lack of awareness and education among patients and healthcare providers
    4. Opportunities
      1.  Revolutionization of microbiome-based therapies by the use of AI-driven technologies
    5. Challenges
      1. Complex regulatory policies and increased investment required for the commercialization of human microbiome products
  6. Global Human Microbiome Market Analysis and Projection, By Product
    1. Segment Overview
    2. Drugs
    3. Probiotics
    4. Prebiotics
    5. Synbiotics
  7. Global Human Microbiome Market Analysis and Projection, By Disease
    1. Segment Overview
    2. Infectious
    3. Gastrointestinal
    4. Endocrine & Metabolic
    5. <<Sub2_se4>>
  8. Global Human Microbiome Market Analysis and Projection, By Type
    1. Segment Overview
    2. BCT/FMT
    3. Live Biotherapeutics
  9. Global Human Microbiome Market Analysis and Projection, By End User
    1. Segment Overview
    2. Hospitals & Clinics
    3. Long-term Care
  10. Global Human Microbiome Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Human Microbiome Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Human Microbiome Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. Seres Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   BiomeBank 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  BioHM Health Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Optibiotix Health plc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Infinant Health Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Exegi Pharma LLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Ferring Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Seed Health, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Pendulum
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Actial Farmaceutica SRL 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Resbiotic
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Biogaia AB
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Vedanta Biosciences Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Human Microbiome Market, By Product, 2024-2035(USD Billion)
  2. Global Drugs, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  3. Global Probiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  4. Global Prebiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  5. Global Synbiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  6. Global Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  7. Global Infectious, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  8. Global Gastrointestinal, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  9. Global Endocrine & Metabolic, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  10. Global Human Microbiome Market, By Type, 2024-2035(USD Billion)
  11. Global BCT/FMT, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  12. Global Live Biotherapeutics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  13. Global Human Microbiome Market, By End User, 2024-2035(USD Billion)
  14. Global Hospitals & Clinics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  15. Global Long-term Care, Human Microbiome Market, By Region, 2024-2035(USD Billion)
  16. North America Human Microbiome Market, By Product, 2024-2035(USD Billion)
  17. North America Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  18. North America Human Microbiome Market, By Type, 2024-2035(USD Billion)
  19. North America Human Microbiome Market, By End User, 2024-2035(USD Billion)
  20. North America Human Microbiome Market, By <<Seg5>>, 2024-2035(USD Billion)
  21. U.S.  Human Microbiome Market, By Product, 2024-2035(USD Billion)
  22. U.S.  Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  23. U.S.  Human Microbiome Market, By Type, 2024-2035(USD Billion)
  24. U.S.  Human Microbiome Market, By End User, 2024-2035(USD Billion)
  25. Canada Human Microbiome Market, By Product, 2024-2035(USD Billion)
  26. Canada Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  27. Canada Human Microbiome Market, By Type, 2024-2035(USD Billion)
  28. Canada Human Microbiome Market, By End User, 2024-2035(USD Billion)
  29. Mexico Human Microbiome Market, By Product, 2024-2035(USD Billion)
  30. Mexico Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  31. Mexico Human Microbiome Market, By Type, 2024-2035(USD Billion)
  32. Mexico Human Microbiome Market, By End User, 2024-2035(USD Billion)
  33. Europe Human Microbiome Market, By Product, 2024-2035(USD Billion)
  34. Europe Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  35. Europe Human Microbiome Market, By Type, 2024-2035(USD Billion)
  36. Europe Human Microbiome Market, By End User, 2024-2035(USD Billion)
  37. Germany Human Microbiome Market, By Product, 2024-2035(USD Billion)
  38. Germany Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  39. Germany Human Microbiome Market, By Type, 2024-2035(USD Billion)
  40. Germany Human Microbiome Market, By End User, 2024-2035(USD Billion)
  41. France Human Microbiome Market, By Product, 2024-2035(USD Billion)
  42. France Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  43. France Human Microbiome Market, By Type, 2024-2035(USD Billion)
  44. France Human Microbiome Market, By End User, 2024-2035(USD Billion)
  45. U.K.  Human Microbiome Market, By Product, 2024-2035(USD Billion)
  46. U.K.  Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  47. U.K.  Human Microbiome Market, By Type, 2024-2035(USD Billion)
  48. U.K.  Human Microbiome Market, By End User, 2024-2035(USD Billion)
  49. Italy Human Microbiome Market, By Product, 2024-2035(USD Billion)
  50. Italy Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  51. Italy Human Microbiome Market, By Type, 2024-2035(USD Billion)
  52. Italy Human Microbiome Market, By End User, 2024-2035(USD Billion)
  53. Spain Human Microbiome Market, By Product, 2024-2035(USD Billion)
  54. Spain Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  55. Spain Human Microbiome Market, By Type, 2024-2035(USD Billion)
  56. Spain Human Microbiome Market, By End User, 2024-2035(USD Billion)
  57. Asia Pacific Human Microbiome Market, By Product, 2024-2035(USD Billion)
  58. Asia Pacific Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  59. Asia Pacific Human Microbiome Market, By Type, 2024-2035(USD Billion)
  60. Asia Pacific Human Microbiome Market, By End User, 2024-2035(USD Billion)
  61. Japan Human Microbiome Market, By Product, 2024-2035(USD Billion)
  62. Japan Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  63. Japan Human Microbiome Market, By Type, 2024-2035(USD Billion)
  64. Japan Human Microbiome Market, By End User, 2024-2035(USD Billion)
  65. China Human Microbiome Market, By Product, 2024-2035(USD Billion)
  66. China Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  67. China Human Microbiome Market, By Type, 2024-2035(USD Billion)
  68. China Human Microbiome Market, By End User, 2024-2035(USD Billion)
  69. India Human Microbiome Market, By Product, 2024-2035(USD Billion)
  70. India Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  71. India Human Microbiome Market, By Type, 2024-2035(USD Billion)
  72. India Human Microbiome Market, By End User, 2024-2035(USD Billion)
  73. South America Human Microbiome Market, By Product, 2024-2035(USD Billion)
  74. South America Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  75. South America Human Microbiome Market, By Type, 2024-2035(USD Billion)
  76. South America Human Microbiome Market, By End User, 2024-2035(USD Billion)
  77. Brazil Human Microbiome Market, By Product, 2024-2035(USD Billion)
  78. Brazil Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  79. Brazil Human Microbiome Market, By Type, 2024-2035(USD Billion)
  80. Brazil Human Microbiome Market, By End User, 2024-2035(USD Billion)
  81. The Middle East and Africa Human Microbiome Market, By Product, 2024-2035(USD   Billion)
  82. The Middle East and Africa Human Microbiome Market, By Disease, 2024-2035(USD   Billion)
  83. The Middle East and Africa Human Microbiome Market, By Type, 2024-2035(USD Billion)
  84. The Middle East and Africa Human Microbiome Market, By End User, 2024-2035(USD Billion)
  85. UAE Human Microbiome Market, By Product, 2024-2035(USD Billion)
  86. UAE Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  87. UAE Human Microbiome Market, By Type, 2024-2035(USD Billion)
  88. UAE Human Microbiome Market, By End User, 2024-2035(USD Billion) 
  89. South Africa Human Microbiome Market, By Product, 2024-2035(USD Billion)
  90. South Africa Human Microbiome Market, By Disease, 2024-2035(USD Billion)
  91. South Africa Human Microbiome Market, By Type, 2024-2035(USD Billion)
  92. South Africa Human Microbiome Market, By End User, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Human Microbiome Market Segmentation
  2. Human Microbiome Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Human Microbiome Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Human Microbiome Market
  20. Human Microbiome Market Segmentation, By Product
  21. Human Microbiome Market For Drugs, By Region, 2024-2035 ($ Billion)
  22. Human Microbiome Market For Probiotics, By Region, 2024-2035 ($ Billion)
  23. Human Microbiome Market For Prebiotics, By Region, 2024-2035 ($ Billion)
  24. Human Microbiome Market For Synbiotics, By Region, 2024-2035 ($ Billion)
  25.  Human Microbiome Market Segmentation, By Disease
  26.  Human Microbiome Market For Infectious, By Region, 2024-2035 ($ Billion)
  27.  Human Microbiome Market For Gastrointestinal, By Region, 2024-2035 ($ Billion)
  28. Human Microbiome Market For Endocrine & Metabolic, By Region, 2024-2035 ($ Billion)
  29. Human Microbiome Market Segmentation, By Type
  30. Human Microbiome Market For BCT/FMT, By Region, 2024-2035 ($ Billion)
  31. Human Microbiome Market For Live Biotherapeutics, By Region, 2024-2035 ($ Billion)
  32. Human Microbiome Market Segmentation, By End User
  33. Human Microbiome Market For Hospitals & Clinics, By Region, 2024-2035 ($ Billion)
  34. Human Microbiome Market For Long-term Care, By Region, 2024-2035 ($ Billion)
  35. Seres Therapeutics: Net Sales, 2024-2035 ($ Billion)
  36. Seres Therapeutics: Revenue Share, By Segment, 2024 (%)
  37. Seres Therapeutics: Revenue Share, By Region, 2024 (%)
  38. BiomeBank: Net Sales, 2024-2035 ($ Billion)
  39. BiomeBank: Revenue Share, By Segment, 2024 (%)
  40. BiomeBank: Revenue Share, By Region, 2024 (%)
  41. BioHM Health Inc.: Net Sales, 2024-2035 ($ Billion)
  42. BioHM Health Inc.: Revenue Share, By Segment, 2024 (%)
  43. BioHM Health Inc.: Revenue Share, By Region, 2024 (%)
  44. Optibiotix Health plc.: Net Sales, 2024-2035 ($ Billion)
  45. Optibiotix Health plc.: Revenue Share, By Segment, 2024 (%)
  46. Optibiotix Health plc.: Revenue Share, By Region, 2024 (%)
  47. Infinant Health Inc.: Net Sales, 2024-2035 ($ Billion)
  48. Infinant Health Inc.: Revenue Share, By Segment, 2024 (%)
  49. Infinant Health Inc.: Revenue Share, By Region, 2024 (%)
  50. Exegi Pharma LLC: Net Sales, 2024-2035 ($ Billion)
  51. Exegi Pharma LLC: Revenue Share, By Segment, 2024 (%)
  52. Exegi Pharma LLC: Revenue Share, By Region, 2024 (%)
  53. Ferring Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
  54. Ferring Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  55. Ferring Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  56. Seed Health, Inc.: Net Sales, 2024-2035 ($ Billion)
  57. Seed Health, Inc.: Revenue Share, By Segment, 2024 (%)
  58. Seed Health, Inc.: Revenue Share, By Region, 2024 (%)
  59. Pendulum.: Net Sales, 2024-2035 ($ Billion)
  60. Pendulum.: Revenue Share, By Segment, 2024 (%)
  61. Pendulum.: Revenue Share, By Region, 2024 (%)
  62. Actial Farmaceutica SRL: Net Sales, 2024-2035 ($ Billion)
  63. Actial Farmaceutica SRL: Revenue Share, By Segment, 2024 (%)
  64. Actial Farmaceutica SRL: Revenue Share, By Region, 2024 (%)
  65. Resbiotic: Net Sales, 2024-2035 ($ Billion)
  66. Resbiotic: Revenue Share, By Segment, 2024 (%)
  67. Resbiotic: Revenue Share, By Region, 2024 (%)
  68. Biogaia AB: Net Sales, 2024-2035 ($ Billion)
  69. Biogaia AB: Revenue Share, By Segment, 2024 (%)
  70. Biogaia AB: Revenue Share, By Region, 2024 (%)
  71. Vedanta Biosciences Inc.: Net Sales, 2024-2035 ($ Billion)
  72. Vedanta Biosciences Inc.: Revenue Share, By Segment, 2024 (%)
  73. Vedanta Biosciences Inc.: Revenue Share, By Region, 2024 (%)
  74. Others: Net Sales, 2024-2035 ($ Billion)
  75. Others: Revenue Share, By Segment, 2024 (%)
  76. Others: Revenue Share, By Region, 2024 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies